drugset / Trial / NCT01895543
Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation
NaSingle-groupOpen-labelTreatment
Summary
Safety and Tolerability Extension Trial for Patients with Chronic Idiopathic Constipation (CIC)
Timeline
- Start
- 2013-09
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elobixibat | Small molecule | 5 mg | — |
| Subject | Elobixibat | Small molecule | 10 mg | — |